Clinical Trials on Gagging During Transesophageal Echocardiography in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
- Foshan Sanshui District People's Hospital
- Rivierduinen, Centre for Personality disorders Jelgersma
- United States Department of Defense (DOD)
- Lilly PharmaceuticalCompany
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Sudimplant SAS - Groupe TBR
- Gunkang Pharmaceuticals, Inc
- Arsha Vidya Tirtha
- Julian Taylor Green
- Iyad Naeem Muhammad, PhD
- Korea Otsuka International Asia Arab
- S-Biotek Holding ApS
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Paulo Sérgio Gomes Nogueira Borges
- Oblikue Consulting
- University of Applied Sciences Jena
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Plethora Solutions Ltd
- Eurotrials Brasil Consultores Cientificos Ltda
- View Full List
Medical Conditions
- Anemia Acute
- Visual Attention Span Deficit
- Chemotherapy-Induced Neutropenia
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Serum Albumin Low
- Puberty, Delayed
- Huntington Chorea
- Testicular Teratoma
- Immunologically-induced Lung Disease
- Brain Tumor, Primary
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Vibration; Exposure
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Deformity Flexion
- Gray Platelet Syndrome
- Hypothermia Following Anesthesia, Sequela
- Blepharospasm of Both Eyelids
- Malaria,Falciparum
- Advance Directive Completion
- Thyroid and Parathyroid Surgery
- View Full List
Drug Interventions
- Pemetrexed
- Bimatoprost 0.03% eye drops
- Vosaroxin
- Oxycodone
- Standard medical therapy
- Sorafenib
- Pegfilgrastim
- Rovalpituzumab tesirine
- ABY-035 i.v.
- Furmonertinib 160 mg
- F520
- Mineralocorticoid receptor antagonist
- MMV390048 120mg
- Celecoxib
- Ebselen
- S-Adenosyl-Methionine
- Cytisine
- Acalabrutinib in combination with VR
- Cyanoacrylate
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Croatia
- Contract Research Organizations in Jordan
- Contract Research Organizations in Kenya
- Contract Research Organizations in Moldova
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Norway
- Contract Research Organizations in Suriname
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Venezuela
- CRO list by country